Global Gene Expression and Transcriptome Sequencing Market Research Report 2025

Publication ID:

PB504258517

Publication Date:

May 2, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Gene Expression and Transcriptome Sequencing was valued at US$ 5123 million in the year 2024 and is projected to reach a revised size of US$ 11310 million by 2031, growing at a CAGR of 12.2% during the forecast period.
Gene expression refers to the process by which information encoded in a gene is used to create functional gene products, such as proteins or non-coding RNAs. It involves the transcription of DNA into RNA and the subsequent translation of RNA into proteins. Gene expression is a fundamental process that plays a crucial role in various biological processes, including development, growth, and maintenance of tissues, as well as response to environmental stimuli.
North American market for Gene Expression and Transcriptome Sequencing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Gene Expression and Transcriptome Sequencing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Gene Expression and Transcriptome Sequencing in Pharmaceutical and Biotechnology is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Gene Expression and Transcriptome Sequencing include Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories, Fluidigm, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gene Expression and Transcriptome Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Expression and Transcriptome Sequencing.
The Gene Expression and Transcriptome Sequencing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Expression and Transcriptome Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Expression and Transcriptome Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Segment by Type
Gene Expression
Transcriptome Sequencing
Segment by Application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Expression and Transcriptome Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Expression and Transcriptome Sequencing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Gene Expression
1.2.3 Transcriptome Sequencing
1.3 Market by Application
1.3.1 Global Gene Expression and Transcriptome Sequencing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical and Biotechnology
1.3.3 Academic Research and Government Institutes
1.3.4 Hospitals and Diagnostic Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Expression and Transcriptome Sequencing Market Perspective (2020-2031)
2.2 Global Gene Expression and Transcriptome Sequencing Growth Trends by Region
2.2.1 Global Gene Expression and Transcriptome Sequencing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gene Expression and Transcriptome Sequencing Historic Market Size by Region (2020-2025)
2.2.3 Gene Expression and Transcriptome Sequencing Forecasted Market Size by Region (2026-2031)
2.3 Gene Expression and Transcriptome Sequencing Market Dynamics
2.3.1 Gene Expression and Transcriptome Sequencing Industry Trends
2.3.2 Gene Expression and Transcriptome Sequencing Market Drivers
2.3.3 Gene Expression and Transcriptome Sequencing Market Challenges
2.3.4 Gene Expression and Transcriptome Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Expression and Transcriptome Sequencing Players by Revenue
3.1.1 Global Top Gene Expression and Transcriptome Sequencing Players by Revenue (2020-2025)
3.1.2 Global Gene Expression and Transcriptome Sequencing Revenue Market Share by Players (2020-2025)
3.2 Global Gene Expression and Transcriptome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gene Expression and Transcriptome Sequencing Revenue
3.4 Global Gene Expression and Transcriptome Sequencing Market Concentration Ratio
3.4.1 Global Gene Expression and Transcriptome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Expression and Transcriptome Sequencing Revenue in 2024
3.5 Global Key Players of Gene Expression and Transcriptome Sequencing Head office and Area Served
3.6 Global Key Players of Gene Expression and Transcriptome Sequencing, Product and Application
3.7 Global Key Players of Gene Expression and Transcriptome Sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Expression and Transcriptome Sequencing Breakdown Data by Type
4.1 Global Gene Expression and Transcriptome Sequencing Historic Market Size by Type (2020-2025)
4.2 Global Gene Expression and Transcriptome Sequencing Forecasted Market Size by Type (2026-2031)
5 Gene Expression and Transcriptome Sequencing Breakdown Data by Application
5.1 Global Gene Expression and Transcriptome Sequencing Historic Market Size by Application (2020-2025)
5.2 Global Gene Expression and Transcriptome Sequencing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gene Expression and Transcriptome Sequencing Market Size (2020-2031)
6.2 North America Gene Expression and Transcriptome Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gene Expression and Transcriptome Sequencing Market Size by Country (2020-2025)
6.4 North America Gene Expression and Transcriptome Sequencing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Expression and Transcriptome Sequencing Market Size (2020-2031)
7.2 Europe Gene Expression and Transcriptome Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gene Expression and Transcriptome Sequencing Market Size by Country (2020-2025)
7.4 Europe Gene Expression and Transcriptome Sequencing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Expression and Transcriptome Sequencing Market Size (2020-2031)
8.2 Asia-Pacific Gene Expression and Transcriptome Sequencing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gene Expression and Transcriptome Sequencing Market Size by Region (2020-2025)
8.4 Asia-Pacific Gene Expression and Transcriptome Sequencing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Expression and Transcriptome Sequencing Market Size (2020-2031)
9.2 Latin America Gene Expression and Transcriptome Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gene Expression and Transcriptome Sequencing Market Size by Country (2020-2025)
9.4 Latin America Gene Expression and Transcriptome Sequencing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Expression and Transcriptome Sequencing Market Size (2020-2031)
10.2 Middle East & Africa Gene Expression and Transcriptome Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gene Expression and Transcriptome Sequencing Market Size by Country (2020-2025)
10.4 Middle East & Africa Gene Expression and Transcriptome Sequencing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Gene Expression and Transcriptome Sequencing Introduction
11.1.4 Thermo Fisher Scientific Revenue in Gene Expression and Transcriptome Sequencing Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Illumina
11.2.1 Illumina Company Details
11.2.2 Illumina Business Overview
11.2.3 Illumina Gene Expression and Transcriptome Sequencing Introduction
11.2.4 Illumina Revenue in Gene Expression and Transcriptome Sequencing Business (2020-2025)
11.2.5 Illumina Recent Development
11.3 QIAGEN (Exiqon)
11.3.1 QIAGEN (Exiqon) Company Details
11.3.2 QIAGEN (Exiqon) Business Overview
11.3.3 QIAGEN (Exiqon) Gene Expression and Transcriptome Sequencing Introduction
11.3.4 QIAGEN (Exiqon) Revenue in Gene Expression and Transcriptome Sequencing Business (2020-2025)
11.3.5 QIAGEN (Exiqon) Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Gene Expression and Transcriptome Sequencing Introduction
11.4.4 Agilent Technologies Revenue in Gene Expression and Transcriptome Sequencing Business (2020-2025)
11.4.5 Agilent Technologies Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Gene Expression and Transcriptome Sequencing Introduction
11.5.4 Roche Revenue in Gene Expression and Transcriptome Sequencing Business (2020-2025)
11.5.5 Roche Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Details
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Gene Expression and Transcriptome Sequencing Introduction
11.6.4 GE Healthcare Revenue in Gene Expression and Transcriptome Sequencing Business (2020-2025)
11.6.5 GE Healthcare Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Gene Expression and Transcriptome Sequencing Introduction
11.7.4 Bio-Rad Laboratories Revenue in Gene Expression and Transcriptome Sequencing Business (2020-2025)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Fluidigm
11.8.1 Fluidigm Company Details
11.8.2 Fluidigm Business Overview
11.8.3 Fluidigm Gene Expression and Transcriptome Sequencing Introduction
11.8.4 Fluidigm Revenue in Gene Expression and Transcriptome Sequencing Business (2020-2025)
11.8.5 Fluidigm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂